Exencial Wealth Advisors LLC Decreases Stock Position in GE HealthCare Technologies Inc. $GEHC

Key Points

• Exencial Wealth Advisors cut its position in GE HealthCare by 37.0% in Q4, selling 63,931 shares and finishing the quarter with 108,974 shares worth about $8.94 million.
• GE HealthCare topped quarterly estimates (EPS $1.44 vs. $1.40; revenue $5.70B) and set FY2026 guidance of EPS 4.95–5.15.
• Analysts’ consensus is a Hold with a $89.77 target (stock opened at $70.48; 12‑month range $66.95–$89.77), and institutional investors hold roughly 82.06% of the shares.

Exencial Wealth Advisors LLC lessened its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 37.0% during the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 108,974 shares of the company's stock after selling 63,931 shares during the period. Exencial Wealth Advisors LLC's holdings in GE HealthCare Technologies were worth $8,938,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also bought and sold shares of the business. Vanguard Group Inc. increased its stake in GE HealthCare Technologies by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 52,275,767 shares of the company's stock worth $4,287,658,000 after purchasing an additional 267,058 shares during the period. Dodge & Cox increased its stake in GE HealthCare Technologies by 16.8% in the third quarter. Dodge & Cox now owns 27,517,311 shares of the company's stock worth $2,066,550,000 after purchasing an additional 3,949,361 shares during the period. Capital Research Global Investors increased its stake in GE HealthCare Technologies by 25.0% in the third quarter. Capital Research Global Investors now owns 24,972,556 shares of the company's stock worth $1,875,400,000 after purchasing an additional 4,998,154 shares during the period. Hotchkis & Wiley Capital Management LLC increased its stake in GE HealthCare Technologies by 17.1% in the third quarter. Hotchkis & Wiley Capital Management LLC now owns 8,432,374 shares of the company's stock worth $633,271,000 after purchasing an additional 1,232,828 shares during the period. Finally, Dimensional Fund Advisors LP increased its stake in GE HealthCare Technologies by 8.9% in the third quarter. Dimensional Fund Advisors LP now owns 5,362,717 shares of the company's stock worth $402,647,000 after purchasing an additional 438,439 shares during the period. Hedge funds and other institutional investors own 82.06% of the company's stock.

Analyst Ratings Changes

GEHC has been the topic of a number of recent analyst reports. Barclays increased their target price on GE HealthCare Technologies from $86.00 to $87.00 and gave the stock an "equal weight" rating in a research note on Friday, February 6th. Stifel Nicolaus increased their target price on GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a "buy" rating in a research note on Wednesday, February 4th. Morgan Stanley increased their price target on GE HealthCare Technologies from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research report on Wednesday, February 4th. Wells Fargo & Company increased their price target on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an "overweight" rating in a research report on Thursday, February 5th. Finally, Citigroup dropped their price target on GE HealthCare Technologies from $88.00 to $84.00 and set a "neutral" rating on the stock in a research report on Wednesday, March 11th. Eight investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $89.77.

GE HealthCare Technologies Price Performance

GEHC opened at $70.48 on Tuesday. GE HealthCare Technologies Inc. has a 12-month low of $66.95 and a 12-month high of $89.77. The company has a current ratio of 1.37, a quick ratio of 1.13 and a debt-to-equity ratio of 0.91. The business's fifty day simple moving average is $74.45 and its 200-day simple moving average is $77.78. The company has a market capitalization of $32.16 billion, a price-to-earnings ratio of 15.46, a PEG ratio of 1.52 and a beta of 1.17.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.40 by $0.04. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business had revenue of $5.70 billion for the quarter, compared to the consensus estimate of $5.60 billion. During the same quarter in the prior year, the company earned $1.45 EPS. The business's revenue was up 7.1% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 5 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Investors of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 3.07%.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.

Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.